PRIORIX VACCINE
Product details
Registration number: SIN10822P
Classification: Prescription Only
Active ingredients:
- MEASLES VIRUS (SCHWARZ STRAIN) (LIVE ATTENUATED)
- MUMPS VIRUS (RIT 4385 STRAIN) (LIVE ATTENUATED)
- RUBELLA VIRUS (RA27/3 STRAIN) (LIVE ATTENUATED)
Strength:
- min 1000 TCID50
- min 5000 TCID50
- min 1000 TCID50
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: SUBCUTANEOUS; INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07BD52
HSA approval date: 22 March 1999
Manufacturer(s):
- Fidia Farmaceutici S.P.A
- Corixa Corporation d/b/a GlaxoSmithKline Vaccines
- Aspen Notre Dame De Bondeville - Diluent in syringes
- Novo Nordisk Production Belgium SA - Diluent in syringes
- Fidia Farmaceutici S.P.A (Diluent in ampoules)
Manufacturing country/countries: UNITED STATES; ITALY; FRANCE; BELGIUM
What are the HSA registration number and classification for PRIORIX VACCINE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN10822P
Classification: Prescription Only
What active ingredients and strength are recorded for PRIORIX VACCINE?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- MEASLES VIRUS (SCHWARZ STRAIN) (LIVE ATTENUATED)
- MUMPS VIRUS (RIT 4385 STRAIN) (LIVE ATTENUATED)
- RUBELLA VIRUS (RA27/3 STRAIN) (LIVE ATTENUATED)
Strength:
- min 1000 TCID50
- min 5000 TCID50
- min 1000 TCID50
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PRIORIX VACCINE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: SUBCUTANEOUS; INTRAMUSCULAR
Who is the recorded registrant for PRIORIX VACCINE?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for PRIORIX VACCINE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Fidia Farmaceutici S.P.A
- Corixa Corporation d/b/a GlaxoSmithKline Vaccines
- Aspen Notre Dame De Bondeville - Diluent in syringes
- Novo Nordisk Production Belgium SA - Diluent in syringes
- Fidia Farmaceutici S.P.A (Diluent in ampoules)
Manufacturing country/countries: UNITED STATES; ITALY; FRANCE; BELGIUM
Where can I look up PRIORIX VACCINE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN10822P or the exact product name PRIORIX VACCINE. The general register link does not preselect this product.
What are the source dates for this PRIORIX VACCINE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PRIORIX VACCINE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN10822P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)